| 000 | 01721 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518090218.0 | ||
| 264 | 0 | _c20210203 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/clinem/dgaa089 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLosa, Marco | |
| 245 | 0 | 0 |
_aGrowth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _c05 2020 |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 |
_aAdenoma _xepidemiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCraniopharyngioma _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHormone Replacement Therapy _xadverse effects |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypophysectomy _xadverse effects |
| 650 | 0 | 4 |
_aHypopituitarism _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xchemically induced |
| 650 | 0 | 4 |
_aNeurosurgical Procedures _xadverse effects |
| 650 | 0 | 4 |
_aPituitary Neoplasms _xepidemiology |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aCastellino, Laura | |
| 700 | 1 | _aPagnano, Angela | |
| 700 | 1 | _aRossini, Alessandro | |
| 700 | 1 | _aMortini, Pietro | |
| 700 | 1 | _aLanzi, Roberto | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 105 _gno. 5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/clinem/dgaa089 _zAvailable from publisher's website |
| 999 |
_c30686510 _d30686510 |
||